Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Biomarkers for Evaluation of Prostate Cancer Prognosis Publisher Pubmed



Esfahani M1 ; Ataei N1 ; Panjehpour M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Clinical Biochemistry and Bioinformatics Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Asian Pacific Journal of Cancer Prevention Published:2015


Abstract

Prostate cancer, with a lifetime prevalence of one in six men, is the second cause of malignancy-related death and the most prevalent cancer in men in many countries. Nowadays, prostate cancer diagnosis is often based on the use of biomarkers, especially prostate-specific antigen (PSA) which can result in enhanced detection at earlier stage and decreasing in the number of metastatic patients. However, because of the low specificity of PSA, unnecessary biopsies and mistaken diagnoses frequently occur. Prostate cancer has various features so prognosis following diagnosis is greatly variable. There is a requirement for new prognostic biomarkers, particularly to differentiate between inactive and aggressive forms of disease, to improve clinical management of prostate cancer. Research continues into finding additional markers that may allow this goal to be attained. We here selected a group of candidate biomarkers including PSA, PSA velocity, percentage free PSA, TGFß1, AMACR, chromogranin A, IL-6, IGFBPs, PSCA, biomarkers related to cell cycle regulation, apoptosis, PTEN, androgen receptor, cellular adhesion and angiogenesis, and also prognostic biomarkers with Genomic tests for discussion. This provides an outline of biomarkers that are presently of prognostic interest in prostate cancer investigation.
Related Docs
View other Related Docs
1. Phosphatase and Tensin Gene Association With Features of Aggressive Prostate Cancer, Translational Research in Urology (2021)
2. Biomarkers for Prostate Cancer Diagnosis From Genetic Perspectives, Translational Research in Urology (2020)
3. Relation Between Serum Level of Total Psa and Free Psa/Total Psa Ratio With Grade of Prostate Cancer, Journal of Isfahan Medical School (2013)
4. Perineural Invasion, Gleason Score and Prostate Specific Antigen; Is There Any Association?, Journal of Nephropathology (2019)
5. Jpx and Linc00641 Ncrnas Expression in Prostate Tissue: A Case-Control Study, Research in Pharmaceutical Sciences (2021)
6. Igf1 Ca-Repeat Polymorphism and Prostate Cancer Development in Isfahan Province of Iran, Journal of Kerman University of Medical Sciences (2018)
7. Comparison of Serum Levels Free and Total Prostate Specific Antigen in Women With Colorectal Cancer and Healthy Women; [مقایسهی سطح سرمی آنتیژن اختصاصی پروستات آزاد و کل در زنان مبتال به سرطان و زنان سالم], Journal of Isfahan Medical School (2024)
8. Discrepancies Between Biopsy Gleason Score and Radical Prostatectomy Specimen Gleason Score: An Iranian Experience, Urology Journal (2019)
Experts (# of related papers)
View all Related Experts
Mohammad Yazdani (5)
Mohammad Hossein Izadpanahi (4)
Other Related Docs
9. Exosomal Noncoding Rnas in Prostate Cancer, Clinica Chimica Acta (2022)
10. The Incidence and Mortality of Prostate Cancer and Its Relationship With Development in Asia, Prostate International (2015)
11. Effect of Ejaculation on Serum Prostate Specific Antigen Level in Screening and Non-Screening Population, Journal of Research in Medical Sciences (2013)
12. Liquid Biopsy in Prostate Cancer Diagnosis and Prognosis: A Narrative Review, Translational Research in Urology (2020)
13. Diagnostic Utility of A-Methylacyl Coa Racemase in Prostate Cancer of the Iranian Population, Journal of Research in Medical Sciences (2021)
14. Diagnostic Values of Serum Total Prostate-Specific Antigen for Detection of Breast Masses Nature in 20-75-Year-Old Women With Breast Mass, Journal of Isfahan Medical School (2017)
15. Clinicopathological Correlation of Insulin-Like Growth Factor Binding Protein 3 and Their Death Receptor in Patients With Gastric Cancer, Research in Pharmaceutical Sciences (2024)
16. Evaluation of the Accuracy of Dynamic Contrast Enhanced Mri in the Diagnosis of Invasive Prostate Neoplasm Using Pathological Findings, Tehran University Medical Journal (2021)
17. The Insulin-Like Growth Factor Binding Protein-3 and Its Death Receptor in Pancreatic Ductal Adenocarcinoma Poor Prognosis, Journal of Cellular Physiology (2019)
18. The Utility of Stat6 and Aldh1 Expression in the Differential Diagnosis of Solitary Fibrous Tumor Versus Prostate-Specific Stromal Neoplasms, Human Pathology (2016)
19. Enhancing Prostate Cancer Cells’ Sensitivity to Flutamide by Resveratrol: An In-Vitro Study, Tissue and Cell (2025)
20. Expression of Adenosine Receptor Subclasses in Malignant and Adjacent Normal Human Prostate Tissues, Prostate (2015)
21. The Burden of Prostate Cancer in North Africa and Middle East, 1990–2019: Findings From the Global Burden of Disease Study, Frontiers in Oncology (2022)
22. Comparison of Relative Frequency of Human Papillomatous Virus by Using of Immiunohistochemistry Method Between Patients With Prostatic Adenocarcinoma or Benign Prostatic Hyperplasia, Journal of Isfahan Medical School (2011)
23. Structure and Function of Fus Gene in Prostate Cancer, Bratislava Medical Journal (2018)
24. Activation of A2b Adenosine Receptor Regulates Ovarian Cancer Cell Growth: Involvement of Bax/Bcl-2 and Caspase-3, Biochemistry and Cell Biology (2015)
25. Is Prostatic Adenocarcinoma in a Relationship With Human Papilloma Virus in Isfahan- Iran, Journal of Research in Medical Sciences (2013)
26. Rate of Clinically Significant Prostate Cancer on Repeated Biopsy After a Diagnosis of Atypical Small Acinar Proliferation, Immunopathologia Persa (2023)
27. Diagnostic Yield of Fusion Magnetic Resonance-Guided Prostate Biopsy Versus Cognitive-Guided Biopsy in Biopsy-Naive Patients: A Head-To-Head Randomized Controlled Trial, Prostate Cancer and Prostatic Diseases (2021)
28. Nanobodies: A Tool to Open New Horizons in Diagnosis and Treatment of Prostate Cancer, Cancer Cell International (2021)
29. Investigation of Prostate Disorders in 614 Patients Attended Alzahra/Urology Ward Between the Years 2013 to 2015 in Isfahan, International Journal of Pharmaceutical and Clinical Research (2016)
30. New Gleason Grade Groups; Epidemiologic Data From Isfahan, Iran Based on the New Classification, Immunopathologia Persa (2022)
31. Evaluation of Neuroendocrine and Proliferative Markers in Prostatic Adenocarcinomas, Iranian Journal of Medical Sciences (2006)
32. Physiological Role of Adenosine and Its Receptors in Tissue Hypoxia-Induced Angiogenesis, Physiology and Pharmacology (2012)
33. Multiparametric Magnetic Resonance Imaging of Prostate Cancer: Association of Quantitative Magnetic Resonance Parameters With Histopathologic Findings, Iranian Journal of Radiology (2017)
34. Determination of Pre/Post Treatment Changes in Prostate Specific Antigen Levels in Patients With Acute Prostatitis, Translational Research in Urology (2022)
35. Incidental Prostate Cancer: A 10-Year Review of a Tertiary Center, Tehran, Iran, Research and Reports in Urology (2018)
36. Lycopene Does Not Affect Prostate-Specific Antigen in Men With Non-Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Nutrition and Cancer (2021)
37. The Study of Taaaa Repeat Polymorphism in P53 Gene and Its Association With Prostate Cancer, Journal of Isfahan Medical School (2016)